Targeting PI3K/AKT pathway in triple-negative breast cancer

被引：39

作者：

Delaloge, Suzette ^{[1
]}

DeForceville, Louise ^{[1
]}

机构：

[1] Gustave Roussy, Dept Med Oncol, F-94800 Villejuif, France

来源：

LANCET ONCOLOGY | 2017年 / 18卷 / 10期

关键词：

TUMORS;

D O I：

10.1016/S1470-2045(17)30514-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1293 / 1294

页数：3

共 7 条

[1] Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].

Bianchini, Giampaolo ;

Balko, Justin M. ;

Mayer, Ingrid A. ;

Sanders, Melinda E. ;

Gianni, Luca .

NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690

[2] A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67 [J].

Jovanovic, Bojana ;

Mayer, Ingrid A. ;

Mayer, Erica L. ;

Abramson, Vandana G. ;

Bardia, Aditya ;

Sanders, Melinda E. ;

Kuba, M. Gabriela ;

Estrada, Monica V. ;

Beeler, J. Scott ;

Shaver, Timothy M. ;

Johnson, Kimberly C. ;

Sanchez, Violeta ;

Rosenbluth, Jennifer M. ;

Dillon, Patrick M. ;

Forero-Torres, Andres ;

Chang, Jenny C. ;

Meszoely, Ingrid M. ;

Grau, Ana M. ;

Lehmann, Brian D. ;

Shyr, Yu ;

Sheng, Quanhu ;

Chen, Sheau-Chiann ;

Arteaga, Carlos L. ;

Pietenpol, Jennifer A. .

CLINICAL CANCER RESEARCH, 2017, 23 (15) :4035-4045

[3]

Kim SB, 2017, LANCET ONCOL

[4] Comprehensive molecular portraits of human breast tumours [J].

Koboldt, Daniel C. ;

Fulton, Robert S. ;

McLellan, Michael D. ;

Schmidt, Heather ;

Kalicki-Veizer, Joelle ;

McMichael, Joshua F. ;

Fulton, Lucinda L. ;

Dooling, David J. ;

Ding, Li ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

Ally, Adrian ;

Balasundaram, Miruna ;

Butterfield, Yaron S. N. ;

Carlsen, Rebecca ;

Carter, Candace ;

Chu, Andy ;

Chuah, Eric ;

Chun, Hye-Jung E. ;

Coope, Robin J. N. ;

Dhalla, Noreen ;

Guin, Ranabir ;

Hirst, Carrie ;

Hirst, Martin ;

Holt, Robert A. ;

Lee, Darlene ;

Li, Haiyan I. ;

Mayo, Michael ;

Moore, Richard A. ;

Mungall, Andrew J. ;

Pleasance, Erin ;

Robertson, A. Gordon ;

Schein, Jacqueline E. ;

Shafiei, Arash ;

Sipahimalani, Payal ;

Slobodan, Jared R. ;

Stoll, Dominik ;

Tam, Angela ;

Thiessen, Nina ;

Varhol, Richard J. ;

Wye, Natasja ;

Zeng, Thomas ;

Zhao, Yongjun ;

Birol, Inanc ;

Jones, Steven J. M. ;

Marra, Marco A. ;

Cherniack, Andrew D. ;

Saksena, Gordon ;

Onofrio, Robert C. ;

Pho, Nam H. .

NATURE, 2012, 490 (7418) :61-70

[5] A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2-advanced breast cancer (BELLE-4) [J].

Martin, M. ;

Chan, A. ;

Dirix, L. ;

O'Shaughnessy, J. ;

Hegg, R. ;

Manikhas, A. ;

Shtivelband, M. ;

Krivorotko, P. ;

Batista Lopez, N. ;

Campone, M. ;

Ruiz Borrego, M. ;

Khan, Q. J. ;

Beck, J. T. ;

Ramos Vazquez, M. ;

Urban, P. ;

Goteti, S. ;

Di Tomaso, E. ;

Massacesi, C. ;

Delaloge, S. .

ANNALS OF ONCOLOGY, 2017, 28 (02) :313-320

[6] Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation [J].

Robson, Mark ;

Im, Seock-Ah ;

Senkus, Elzbieta ;

Xu, Binghe ;

Domchek, Susan M. ;

Masuda, Norikazu ;

Delaloge, Suzette ;

Li, Wei ;

Tung, Nadine ;

Armstrong, Anne ;

Wu, Wenting ;

Goessl, Carsten ;

Runswick, Sarah ;

Conte, Pierfranco .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (06) :523-533

[7] A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors [J].

Saura, Cristina ;

Roda, Desamparados ;

Rosello, Susana ;

Oliveira, Mafalda ;

Macarulla, Teresa ;

Alejandro Perez-Fidalgo, Jose ;

Morales-Barrera, Rafael ;

Manuel Sanchis-Garcia, Juan ;

Musib, Luna ;

Budha, Nageshwar ;

Zhu, Jin ;

Nannini, Michelle ;

Chan, Wai Y. ;

Bohorquez, Sandra M. Sanabria ;

Meng, Raymond D. ;

Lin, Kui ;

Yan, Yibing ;

Patel, Premal ;

Baselga, Jose ;

Tabernero, Josep ;

Cervantes, Andres .

CANCER DISCOVERY, 2017, 7 (01) :102-113

← 1 →